Top 52 alternative sites to venclextahcp.com
-
venclexta.com
-
onco360.com
-
sunnypharma.info
-
calquencehcp.com
-
rituxan.com
-
rituxan-hcp.com
-
rituxanhycela.com
-
onuregpro.com
-
rydapt.com
-
onureg.com
-
zeposiahcp.com
-
targadox.com
-
xareltohcp.com
-
nexlizet.com
-
mavenclad.com
-
alecensa.com
-
tibsovopro.com
-
rubracahcp.com
-
ocalivahcp.com
-
botoxmedical.com
-
opdivoyervoymnsclc.com
-
teflaro.com
-
xofluza-hcp.com
-
enspryng-hcp.com
-
jentadueto.com
-
gocovri.com
-
sympazan.com
-
otezlapro.com
-
abilifymaintenahcp.com
-
evotazhcp.com
-
topamax.com
-
otrexup.com
-
fetzimahcp.com
-
gocovrihcp.com
-
nurtec-hcp.com
-
dupixenthcp.com
-
monjuvi.com
-
plegridyhcp.com
-
oxtellarxr.com
-
actemrahcp.com
-
nutropin.com
-
avastin.com
-
ofevhcp.com
-
monjuvihcp.com
-
lybalvi.com
-
xywavhcp.com
-
quirem.com
-
lasikworld.com
-
xolairhcp.com
-
lucentis.com
-
xolair.com
-
discovertrk.com
VENCLEXTA® (venetoclax tablets)
Discover VENCLEXTA®. See Full Prescribing and Safety Info.
Onco360 Oncology Specialty Pharmacy | Onco360
Onco360 provides Oncology Specialty Pharmacy services for Patients Physicians Pharma Payers & Hospitals with access to the latest in oncology medication
Author: Onco; Lewis Southwick
Hepatitis C Treatment Cost is Rigged and Why You Should Not Pay $84K
Hepatitis C treatment cost is so high you may die without treatment. This is called rigging the price so people cannot afford it.
MCL and CLL/SLL Treatment | CALQUENCE® (acalabrutinib) 100 mg capsules | For HCPs
CALQUENCE® (acalabrutinib) is a BTK inhibitor indicated for the treatment of adult patients with R/R Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).
RITUXAN® (rituximab) Medication for RA, NHL, CLL, GPA, MPA & PV
Find info for patients about RITUXAN® (rituximab) medication for RA, NHL, CLL, GPA, MPA, and PV. See full safety and Boxed Warning for more information.
Treatment for RA, NHL, CLL, GPA, MPA and PV | RITUXAN® (rituximab)
HCP info about RITUXAN® (rituximab) treatment for RA, NHL, CLL, GPA, MPA and PV including indications, dosing, efficacy and support. Please see Important Safety Information including Boxed Warning and Full Prescribing Information for more information.
RITUXAN HYCELA for FL, DLBCL and CLL
Learn about RITUXAN HYCELA® for subcutaneous injection, a prescription antibody therapy used for FL, DLBCL and CLL. See important safety including Boxed Warnings for more information.
ONUREG® (azacitidine) for Acute Myeloid Leukemia (AML)
Learn about ONUREG®, an AML continued treatment. Register to receive updates. See safety info and full Prescribing Information.
RYDAPT® (midostaurin) Capsules | AML & ASM Treatment
Official HCP website for RYDAPT® (midostaurin). Find indication, treatment, MOA & full safety information here.
ONUREG® (azacitidine) Tablets for Acute Myeloid Leukemia (AML)
ONUREG® is the first and only FDA-approved continued AML treatment for patients in first remission. Register to receive more info. See safety info and full Prescribing Info.
ZEPOSIA® (ozanimod) for MS and UC | Official HCP Website
Discover more about once-daily ZEPOSIA® — an **** therapy for your appropriate patients. See full Safety and Prescribing Info on the official HCP site
Targadox – Targadox
Important Safety Information Targadox® is indicated as adjunctive therapy for severe acne.1 Targadox is the smallest branded doxycycline tablet available in the United States.2 Click on the button below to print a Patient Savings Card Patient Savings Card Indications and Usage TARGADOX (doxycycline hyclate
Author: Doug
XARELTO® (rivaroxaban) Information for Healthcare Professionals
XARELTO® is a treatment indicated for patients with NVAF, DVT/PE, or chronic CAD/PAD. See full Safety & Prescribing Info, with Boxed WARNINGS.
NEXLETOL® (bempedoic acid) | Official Patient Site
It’s time to break the cycle with NEXLETOL, an ****, once-daily nonstatin therapy for adult patients. Please see Important Safety Information.
MAVENCLAD® (cladribine) tablets
Learn about MAVENCLAD, an **** therapy. See Full Prescribing and Safety Information, including BOXED WARNING.
ALECENSA® (alectinib) and Information for Patients
Find information for patients about treatment with ALECENSA® (alectinib). See full safety for more information.
TIBSOVO® (ivosidenib tablets) an IDH1 Inhibitor
TIBSOVO® treatment for patients with Acute Myeloid Leukemia or Cholangiocarcinoma. See full indications, prescribing information, & boxed warning.
Rubraca® (rucaparib) | Information for Healthcare Professionals
Learn about Rubraca® (rucaparib), a PARP inhibitor approved to treat and benefit patients in 3 indications across 2 tumor types. Please see Indications and Important Safety Information.
Primary Biliary Cholangitis Treatment – OCALIVA® (obeticholic acid) | Official US HCP Site
See Full Prescribing Information and Boxed Warning. Review the indication, safety profile, efficacy data, and dosage information. Access practice and patient resources.
Other sites like venclextahcp com
Results
Access exclusive BOTOX® training resources and learn about BOTOX® indications. See full safety and Prescribing Information including Boxed Warning.
1L mNSCLC Treatment | OPDIVO® (nivolumab) + YERVOY® (ipilimumab) Combination
OPDIVO® (nivolumab) + YERVOY® (ipilimumab) is approved as a first-line treatment for eligible metastatic non-small cell lung cancer patients. Please see Indication and Important Safety Information.
ABSSSI & CABP IV Therapy | TEFLARO® (ceftaroline fosamil)
Learn about TEFLARO®, an infusion therapy that may be prescribed to patients with ABSSSI or CABP. See Safety & Prescribing Information.
Single-dose Flu Antiviral | XOFLUZA® (baloxavir marboxil) HCP
Find information for HCPs about XOFLUZA® (baloxavir marboxil), a single-dose **** antiviral treatment for influenza. See full safety for more information.
ENSPRYNG™ (satralizumab) | Efficacy, Safety, & Prescribing Information
ENSPRYNG™ (satralizumab) is an interleukin-6 (IL-6) receptor antagonist indicated as monotherapy or with immunosuppressive therapy for the treatment of NMOSD. See full safety for more information.
Jentadueto® (linagliptin / metformin HCI) Tablets | Patients Site
Jentadueto® (linagliptin / metformin HCI) Tablets. View Important Safety Information and full Prescribing Information, including boxed warning.
GOCOVRI® (amantadine) extended release capsules
GOCOVRI® (amantadine) helps treat dyskinesia in patients receiving levodopa therapy for Parkinson's disease. Learn more about how GOCOVRI can help, hear from real patients, and find out how to get started. See full safety information.
SYMPAZAN (clobazam) **** Film | Official Caregivers Site
Learn about SYMPAZAN (clobazam) **** film with PharmFilm® technology. See Important Safety Information and full Prescribing Information, including Boxed Warning, on this website.
Official Home Page of the Otezla® (apremilast) Healthcare Professional Site | Amgen Inc.
Learn about Otezla® (apremilast), a treatment for adults with moderate to severe plaque psoriasis, active psoriatic arthritis, or **** ulcers associated with Behçet's disease. Review the mechanism of action (MOA), the clinical trial program, efficacy data, and safety information. Access educational materials for your patients and information about prescribing and starting patients on Otezla. Please see full Important Safety Information.
Schizophrenia Treatment & Bipolar I Maintenance | ABILIFY MAINTENA® (aripiprazole)
ABILIFY MAINTENA® (aripiprazole) is indicated for the treatment of schizophrenia and for Bipolar I maintenance monotherapy in adults. See full Safety and Prescribing Information, including BOXED WARNING.
EVOTAZ® (atazanavir/cobicistat) **** Treatment | For Healthcare Providers
Learn about EVOTAZ® (atazanavir/cobicistat) for treatment-naïve patients with ****-1. See Full Prescribing Safety Information.
TOPAMAX® | Eligible Patients Can Pay $4 TOPAMAX® (topiramate) Savings Program
TOPAMAX® (topiramate) for migraine prevention in adults. Eligible Patients Can Pay $4 with TOPAMAX® (topiramate) Savings Program. See Important Safety Information & full Prescribing Information.
Otrexup® (methotrexate) injection for subcutaneous use
Otrexup® is a once-weekly subcutaneous administered form of methotrexate for patients with RA. See Boxed Warning, Important Safety Information, and Full Prescribing Information.
FETZIMA® (levomilnacipran) ER Capsules | HCP Official Site
Choose FETZIMA® as a treatment for your appropriate adult MDD patients. See safety info, including Boxed Warning & full Prescribing Information.
GOCOVRI® (amantadine) extended release capsules
GOCOVRI® (amantadine) is an extended-release dyskinesia treatment for patients with Parkinson’s disease receiving levodopa-based therapy. See safety & prescribing information & learn more.
Nurtec® ODT (rimegepant) | For Healthcare Professionals
Nurtec® ODT (rimegepant) is indicated for the acute treatment of migraine and the preventive treatment of episodic migraine in adults. See safety & efficacy data and view full Prescribing Information.
Now Approved as Add-on Maintenance Treatment in Patients (12+) with Moderate-to-Severe Asthma with an Eosinophilic Phenotype or **** Cortico
DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is approved for 3 indications. Serious adverse reactions may occur. Please see Important Safety Information and full Prescribing Information on website.
MONJUVI® (tafasitamab-cxix) 200mg: Treatment for R/R DLBCL
MONJUVI® (tafasitamab-cxix) for relapsed/refractory (R/R) DLBCL is a 200mg injection for intravenous use. Please see the full Prescribing Information, including Patient Information, for additional Important Safety Information.
Relapsing MS Treatment | PLEGRIDY® (peginterferon beta-1a) | HCP Site
Official Healthcare Professional site for PLEGRIDY® (peginterferon beta-1a). Find info for your Relapsing MS patients here. See full Prescribing & Safety Information.
Partial Seizure Treatment | Oxtellar XR® (oxcarbazepine)
Learn how Oxtellar XR® extended-release tablets are designed to help people living with partial-onset seizures. See Full Prescribing & Safety Information.
What else venclextahcp.com alternative websites
IMPORTANT SAFETY INFORMATION
HCP info about ACTEMRA® (tocilizumab) treatment for SJIA, PJIA, GCA, SSc-ILD, & RA patients. See Full Safety and Boxed Warnings for more information.
Designed to be Simple
Find information about Nutropin AQ® (somatropin) injection, for subcutaneous use HGH Injection therapy, read about Nutropin GPS co-pay card and learn about the Nutropin AQ® regimen. See full safety for more information.
GET FINANCIAL SUPPORT
Learn about Avastin® (bevacizumab) solution for IV infusion, including benefits, risks, possible side effects, patient support, and options for financial help. See full safety for more information.
OFEV® (nintedanib) for IPF, SSc-ILD & Chronic Fibrosing ILDs with a Progressive Phenotype
Learn about OFEV® (nintedanib), an option for patients with Idiopathic Pulmonary Fibrosis (IPF), Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD), & Chronic Fibrosing ILDs with a Progressive Phenotype. View full prescribing information, including patient information and important safety information.
MONJUVI® (tafasitamab-cxix): Treatment for R/R DLBCL | Official HCP Site
MONJUVI® (tafasitamab-cxix) 200 mg for injection, targeted immunotherapy for intravenous use in R/R DLBCL and recommended by NCCN Guidelines®. Please see 1-year and 3-year follow-up data and the full PI, including Patient Information, for additional Important Safety Information.
LYBALVI® (olanzapine and samidorphan) Is Now Available | Official Website | Alkermes®
Please see Important Safety Information and full Prescribing Information, including Boxed Warning, and Medication Guide. LYBALVI® (olanzapine and samidorphan) is Now Available. Register to receive updates. Learn how commercially insured eligible patients may be able to to save on their LYBALVI prescription. Program terms and conditions apply.
XYWAV Official Healthcare Provider (HCP) Site
For healthcare professionals, XYWAV® (calcium, magnesium, potassium, and sodium oxybates) **** solution is approved for patients with cataplexy and/or excessive daytime sleepiness (EDS) in narcolepsy, and for adults with idiopathic hypersomnia (IH). See full Prescribing Information & BOXED Warning about serious side effects, CNS depression, and misuse and abuse.
Home - Quirem
You are unique, and so should your treatment be.To learn more about Selective Internal Radiation Therapy (SIRT) and the unique benefits of our products, visit our patient information website.Read morePerform treatment planning with Q-suite®Q-suite® is software for dosimetric verification of Ho-166 SIRT. A workflow-based user interface makes Q-suite® easy to learn and use.Learn more SIRT […]
LASIK & Family Eye Care with Griffin & Reed
We are open! Click here for an update on the safety guidelines we are following! Safety Guidelines Welcome to Griffin & Reed Eye Care: Serving laser vision correction, general eye care, optical, cataract and ReSTOR® surgery patients in Northern California. We're proud to present the latest procedures and technologies to correct your vision with safety and precision. Our goal is to produce the most informative, independent vision correction website available. Our website is packed full of important information, not just the standard information you are used to reading on other sites.
Some websites with similar theme to venclextahcp.com include:
XOLAIR® (omalizumab)
Learn about XOLAIR® (omalizumab) for allergic asthma uncontrolled on inhaled corticosteroids, chronic idiopathic urticaria (CIU) and nasal polyps. See full safety & boxed warning.
LUCENTIS®: Wet AMD, DR, DME, mCNV & RVO Treatment Option
Learn about LUCENTIS (ranibizumab injection), a treatment option for wet AMD, diabetic macular edema (DME), diabetic retinopathy (DR), mCNV, & RVO. See full safety for more information.
XOLAIR® (Omalizumab) for Allergic Asthma, Nasal Polyps & CIU Treatment
XOLAIR® (omalizumab) is a treatment for nasal polyps, allergic asthma & chronic idiopathic urticaria (CIU). See full prescribing, safety, & Boxed Warning info.
Author: Which condition below are you interested in
What is TRK? | TRK Fusion Cancer
Find information on TRK, a possible primary oncogenic driver, and how patients with TRK fusions require early molecular testing in order to receive targeted therapy.
